Syngene International Announces Q3 Results Review Meeting on January 22

0 min read     Updated on 08 Jan 2026, 01:55 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Syngene International has scheduled a board meeting for January 22 to consider its third quarter financial results. The healthcare company will review Q3 performance during this meeting, following standard corporate governance practices for quarterly result announcements.

29406325

*this image is generated using AI for illustrative purposes only.

Syngene International has announced that its board of directors will convene on January 22 to consider the company's third quarter financial results. The healthcare sector company will review its Q3 performance during this scheduled meeting.

Board Meeting Details

The upcoming board meeting represents a standard quarterly review process for the publicly listed company. During this session, the board will examine the financial performance and operational metrics for the third quarter period.

Meeting Details: Information
Date: January 22
Purpose: Q3 Results Consideration
Company: Syngene International
Sector: Healthcare

Corporate Governance

This announcement aligns with standard corporate governance practices for listed companies, where quarterly results are regularly reviewed and approved by the board of directors before public disclosure. The meeting will provide stakeholders with insights into the company's third quarter operational and financial performance.

Investors and market participants will be awaiting the outcomes of this board meeting to understand Syngene International's quarterly performance metrics and business developments during the review period.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
-0.36%-3.01%-0.25%-0.32%-27.60%+4.57%
Syngene International
View in Depthredirect
like15
dislike

Syngene International Wins Tax Litigation Case, Secures ₹48.90 Crore Refund Order

1 min read     Updated on 30 Dec 2025, 11:51 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Syngene International has secured a favorable ruling from the High Court of Karnataka in its tax litigation case, with the court directing income tax authorities to refund ₹48.90 crores with interest for assessment years 2010-11, 2011-12, and 2012-13. The company expects no material impact on its financials or operations from this positive development.

28664482

*this image is generated using AI for illustrative purposes only.

Syngene International has secured a significant legal victory in its ongoing tax litigation, with the High Court of Karnataka passing a favorable order on December 17. The pharmaceutical services company announced this development through a regulatory filing dated December 30.

Court Order Details

The High Court of Karnataka has allowed the writ petition filed by Syngene International against income tax authorities. The case pertained to issues related to assessment years 2010-11, 2011-12, and 2012-13, involving a substantial refund amount.

Parameter: Details
Court: High Court of Karnataka
Order Date: December 17
Assessment Years: 2010-11, 2011-12, 2012-13
Total Refund Amount: ₹48.90 crores
Communication Received: December 30

Background of the Dispute

The company had filed the writ petition against specific actions by income tax authorities. The dispute centered around two main issues:

  • Adjustment of refund granted for assessment years 2010-11 and 2011-12 against demand outstanding for other years
  • Non-issuance of refund granted for assessment year 2012-13

The total amount involved in this tax litigation aggregated to ₹48,90,84,008.

Court's Direction

The High Court has provided clear directions to resolve the matter in favor of Syngene International. The court has directed income tax authorities to refund the amount along with interest, subject to verification. Notably, no penalties, restrictions, or sanctions have been imposed in the current order.

Financial Impact Assessment

Aspect: Company's Position
Financial Impact: No material impact expected
Operations: No disruption anticipated
Activities: Normal business continuation
Compliance: No aberrations identified

Syngene International has stated that it believes there may not be any material impact on the company's financials, operations, or activities as a result of this favorable order.

Next Steps

The company is currently analyzing the court order and will take appropriate action as required. This development represents an update to the company's previous intimation dated October 16, regarding the filing of the writ petition before the High Court of Karnataka.

The favorable court ruling strengthens Syngene International's position in this tax matter and provides clarity on the refund process for the specified assessment years.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
-0.36%-3.01%-0.25%-0.32%-27.60%+4.57%
Syngene International
View in Depthredirect
like20
dislike
More News on Syngene International
Explore Other Articles
630.60
-2.30
(-0.36%)